Literature DB >> 1316493

Mechanism of action of the papillomavirus E2 repressor: repression in the absence of DNA binding.

J Barsoum1, S S Prakash, P Han, E J Androphy.   

Abstract

Repression of papillomavirus E2-dependent gene expression was studied by using transient transfections into mouse embryo fibroblast cells. Cotransfection of a gene corresponding to the naturally occurring repressor E2-TR along with the full-length E2 gene resulted in up to 98% repression of E2-dependent reporter gene expression. A series of E2 DNA-binding domain mutants were transferred into the E2-TR form and characterized for their ability to repress E2-dependent transactivation. All mutants which were defective for DNA binding but were dimerization competent repressed E2 transactivation as well or nearly as well as the wild-type repressor. E2 mutants which lacked dimerization activity repressed transactivation poorly or not at all. These results indicate that the E2 repressor can inhibit transcription, in the absence of DNA binding, by forming heterodimers with full-length E2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316493      PMCID: PMC241186     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  I-POU: a POU-domain protein that inhibits neuron-specific gene activation.

Authors:  M N Treacy; X He; M G Rosenfeld
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

2.  The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops.

Authors:  J D Knight; R Li; M Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Genetic assignment of multiple E2 gene products in bovine papillomavirus-transformed cells.

Authors:  P F Lambert; N L Hubbert; P M Howley; J T Schiller
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

4.  Trans activation by the bovine papillomavirus E2 protein in Saccharomyces cerevisiae.

Authors:  L C Morrissey; J Barsoum; E J Androphy
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs.

Authors:  J Choe; P Vaillancourt; A Stenlund; M Botchan
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

6.  E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain.

Authors:  A A McBride; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Evidence for cooperativity between E2 binding sites in E2 trans-regulation of bovine papillomavirus type 1.

Authors:  B A Spalholz; J C Byrne; P M Howley
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity.

Authors:  A A McBride; R Schlegel; P M Howley
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

10.  The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer.

Authors:  P Hawley-Nelson; E J Androphy; D R Lowy; J T Schiller
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more
  27 in total

1.  The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.

Authors:  F Stubenrauch; T Zobel; T Iftner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Relationship between retroviral DNA integration and gene expression.

Authors:  J B Weidhaas; E L Angelichio; S Fenner; J M Coffin
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Alleviation of human papillomavirus E2-mediated transcriptional repression via formation of a TATA binding protein (or TFIID)-TFIIB-RNA polymerase II-TFIIF preinitiation complex.

Authors:  S Y Hou; S Y Wu; T Zhou; M C Thomas; C M Chiang
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  Characterization of the functional activities of the bovine papillomavirus type 1 E2 protein single-chain heterodimers.

Authors:  Reet Kurg; Helena Tekkel; Aare Abroi; Mart Ustav
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

5.  E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death.

Authors:  Joanna L Parish; Anna Kowalczyk; Hsin-Tien Chen; Geraldine E Roeder; Richard Sessions; Malcolm Buckle; Kevin Gaston
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 6.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

7.  Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.

Authors:  E C Goodwin; L K Naeger; D E Breiding; E J Androphy; D DiMaio
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

8.  Design and characterization of an enhanced repressor of human papillomavirus E2 protein.

Authors:  Kakoli Bose; Gretchen Meinke; Andrew Bohm; James D Baleja
Journal:  FASEB J       Date:  2011-04-11       Impact factor: 5.191

9.  Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.

Authors:  D A Francis; S I Schmid; P M Howley
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

10.  The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes.

Authors:  F Stubenrauch; M Hummel; T Iftner; L A Laimins
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.